Accumulation of fibronectin in the heart after myocardial infarction: a putative stimulator of adhesion and proliferation of adipose-derived stem cells
Open Access
- 28 February 2008
- journal article
- Published by Springer Science and Business Media LLC in Cell and tissue research
- Vol. 332 (2), 289-298
- https://doi.org/10.1007/s00441-008-0573-0
Abstract
Stem cell therapy is a promising treatment after myocardial infarction (MI). A major problem in stem cell therapy, however, is that only a small proportion of stem cells applied to the heart can survive and differentiate into cardiomyocytes. We hypothesized that fibronectin in the heart after MI might positively affect stem cell adhesion and proliferation at the site of injury. Therefore, we investigated the kinetics of attachment and proliferation of adipose-tissue-derived stem cells (ASC) on fibronectin and analysed the time frame and localization of fibronectin accumulation in the human heart after MI. ASCs were seeded onto fibronectin-coated and uncoated culture wells. The numbers of adhering ASC were quantified after various incubation periods (5–30 min) by using DNA quantification assays. The proliferation of ASC was quantified after culturing ASC for various periods (0–9 days) by using DNA assays. Fibronectin accumulation after MI was quantified by immunohistochemical staining of heart sections from 35 patients, after different infarction periods (0–14 days old). We found that ASC attachment and proliferation on fibronectin-coated culture wells was significantly higher than on uncoated wells. Fibronectin deposition was significantly increased from 12 h to 14 days post-infarction, both in the infarction area and in the border-zone, compared with the uninfarcted heart. Our results suggest that a positive effect of fibronectin on stem cells in the heart can only be achieved when stem cell therapy is applied at least 12 h after MI, when the accumulation of fibronectin occurs in the infarcted heart.Keywords
This publication has 40 references indexed in Scilit:
- Stem cell therapy for myocardial regeneration: creating hype ignoring realityEuropean Journal of Cardio-Thoracic Surgery, 2005
- Substrate Induction of Osteogenesis from Marrow-Derived Mesenchymal PrecursorsStem Cells and Development, 2005
- The role of stem cells in cardiac regenerationJournal of Cellular and Molecular Medicine, 2005
- Molecular and cellular events at the site of myocardial infarction: from the perspective of rebuilding myocardial tissueBiochemical and Biophysical Research Communications, 2004
- Adult stem cell therapy for the heartThe International Journal of Biochemistry & Cell Biology, 2004
- Strategies for directing the differentiation of stem cells into the cardiomyogenic lineage in vitroCardiovascular Research, 2004
- Delayed Reperfusion Alters Matrix Metalloproteinase Activity and Fibronectin mRNA Expression in the Infarct Zone of the Ligated Rat HeartJournal of Molecular and Cellular Cardiology, 1997
- Increased Expression of Fibronectin Isoforms After Myocardial Infarction in RatsJournal of Molecular and Cellular Cardiology, 1997
- Sequential Changes in Laminin and Type IV Collagen in the Infarct ZoneJapanese Circulation Journal, 1996
- Fibronectin Penetration into Heart Myocytes Subjected to Experimental Ischemia by Coronary Artery LigationCells Tissues Organs, 1995